• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Wisconsin Tamoxifen Study: toxicity in node-negative postmenopausal women.

作者信息

Love R R

机构信息

University of Wisconsin Clinical Cancer Center, Madison, Wisconsin.

出版信息

Cancer Invest. 1988;6(5):601-5. doi: 10.3109/07357908809082126.

DOI:10.3109/07357908809082126
PMID:3063340
Abstract
摘要

相似文献

1
The Wisconsin Tamoxifen Study: toxicity in node-negative postmenopausal women.威斯康星他莫昔芬研究：绝经后淋巴结阴性女性的毒性反应
Cancer Invest. 1988;6(5):601-5. doi: 10.3109/07357908809082126.
2
Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double-blind comparison with placebo.
Ann Intern Med. 1985 Sep;103(3):324-9. doi: 10.7326/0003-4819-103-3-324.
3
The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
Eur J Cancer (1965). 1980;Suppl 1:83-8.
4
Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.他莫昔芬与氨鲁米特及他莫昔芬联合氨鲁米特治疗绝经后晚期乳腺癌的随机试验
Oncology. 1988;45(5):350-3. doi: 10.1159/000226639.
5
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.辅助性CMFP方案与CMFP方案加他莫昔芬对比单纯观察用于绝经后、淋巴结阳性乳腺癌患者：东部肿瘤协作组一项研究的三年结果
J Clin Oncol. 1985 Feb;3(2):144-54. doi: 10.1200/JCO.1985.3.2.144.
6
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.一项评估他莫昔芬治疗雌激素受体阳性、淋巴结阴性乳腺癌患者疗效的随机临床试验。
N Engl J Med. 1989 Feb 23;320(8):479-84. doi: 10.1056/NEJM198902233200802.
7
A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd.两种剂量他莫昔芬（诺瓦得士）治疗绝经后晚期乳腺癌女性的比较：每日两次，每次10毫克与每日两次，每次20毫克。
Br J Cancer. 1984 Aug;50(2):199-205. doi: 10.1038/bjc.1984.163.
8
Tamoxifen in axillary node--negative breast cancer: multisystem benefits and risks.他莫昔芬用于腋窝淋巴结阴性乳腺癌：多系统益处与风险
Cancer Invest. 1992;10(6):587-93. doi: 10.3109/07357909209024821.
9
A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer.他莫昔芬与他莫昔芬联合氨鲁米特治疗绝经后晚期乳腺癌的随机试验。
Cancer Chemother Pharmacol. 1985;14(3):272-3. doi: 10.1007/BF00258132.
10
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.淋巴结阳性乳腺癌患者化疗后辅助他莫昔芬治疗超过五年。东部肿瘤协作组。
J Natl Cancer Inst. 1996 Dec 18;88(24):1828-33. doi: 10.1093/jnci/88.24.1828.

引用本文的文献

1
Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.第十四届加德姆纪念讲座。他莫昔芬治疗和预防乳腺癌的现状
Br J Pharmacol. 1993 Oct;110(2):507-17. doi: 10.1111/j.1476-5381.1993.tb13840.x.
2
Protein S and protein C level changes with adjuvant tamoxifen therapy in postmenopausal women.绝经后女性接受他莫昔芬辅助治疗时蛋白质S和蛋白质C水平的变化。
Breast Cancer Res Treat. 1994;30(3):311-4. doi: 10.1007/BF00665973.